quipazine has been researched along with Hyperactivity, Motor in 2 studies
Quipazine: A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Following chronic administration of clenbuterol (5 mg/kg daily for 14 days), a procedure resulting in down-regulation of central beta-adrenoceptors, a larger dose of clenbuterol was necessary to enhance the quipazine-induced hyperactivity, suggesting that the mechanism of enhancement involved central post-synaptic beta-adrenoceptors." | 1.27 | Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat. ( Cowen, PJ; Deakin, JF; Grahame-Smith, DG; Green, AR; Heal, DJ; Nimgaonkar, VL, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nimgaonkar, VL | 1 |
| Green, AR | 1 |
| Cowen, PJ | 1 |
| Heal, DJ | 1 |
| Grahame-Smith, DG | 1 |
| Deakin, JF | 1 |
| Langlais, PJ | 1 |
| Gabay, S | 1 |
2 other studies available for quipazine and Hyperactivity, Motor
| Article | Year |
|---|---|
Studies on the mechanisms by which clenbuterol, a beta-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the rat.
Topics: Animals; Behavior, Animal; Brain; Carbidopa; Clenbuterol; Ethanolamines; Fenclonine; Humans; Hydroxy | 1983 |
Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
Topics: Animals; Behavior, Animal; Brain; Dopamine; Female; Haloperidol; Humans; Hyperkinesis; Methysergide; | 1977 |